ScienceDaily (2010-06-04) -- Researchers have stopped a clinical trial evaluating a new approach to reduce the risk of recurrent stroke in children with sickle cell anemia and iron overload because of evidence that the new treatment was unlikely to prove better than the existing treatment.
停止了兒童鐮狀細胞性貧血的研究,以降低中風復發的危險。
sickle cell anemia:鐮狀細胞性貧血
recurrent stroke:中風復發
Story Source:
The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by NIH/National Heart, Lung and Blood Institute.
No comments:
Post a Comment